Aaron Novy, PA
Surgical · N Dartmouth, MANPI 1194028829
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $106 and has fallen 73.8% since, to $28 in 2025. That places this record below the midpoint for surgical clinicians in MA, where the typical reported total is $218.
Across 9 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$37
- CSL Behring$28
- Boston Scientific$25
- Abbott$25
- Biogen$24
- AbbVie$22
- plus $38 from 2 others
What the payments were for
- Food & beverage$198100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| CSL Behring | 1 | $28 |
| Boston Scientific | 1 | $25 |
| Abbott | 1 | $25 |
| Biogen | 1 | $24 |
| AbbVie | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Argenx US, Inc. | 1 | $17 |
How this compares
$198 in reported general payments places this provider in the 45th percentile of 312 surgical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 65 | $490 |
| Gabapentin | 13 | $215 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $160 |
| Oxycodone Hcl | 29 | $139 |
Paid to pharmacies, not to this prescriber.
Other surgical in N Dartmouth
- Gregory DeconciliisWaltham$27K
- Lampros MinosWaltham$18K
- Nicolas DesjardinsSomerville$10K
- Robert KenneyChestnut Hill$8K
- Michael LlewellynBoston$8K
- Anargyros SkaliotisNorth Dartmouth$7K
- Caily IrwinCambridge$6K
- Courtney FioreDanvers$6K
- Dana GoldenseBoston$5K
- Stephanie PenaNatick$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.